Pharmacokinetics of teniposide (VM 26) after IV administration in serum and malignant ascites of patients with ovarian carcinoma. (Q52680277)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 1985

Language	Label	Description	Also known as
English	Pharmacokinetics of teniposide (VM 26) after IV administration in serum and malignant ascites of patients with ovarian carcinoma.	scientific article published in January 1985

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/4017164

Pharmacokinetics of teniposide (VM 26) after IV administration in serum and malignant ascites of patients with ovarian carcinoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/4017164

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

P Canal

1

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/4017164

R Bugat

2

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/4017164

C Michel

3

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/4017164

H Roche

4

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/4017164

G Soula

5

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/4017164

P F Combes

6

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/4017164

publication date

1 January 1985

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/4017164

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/4017164

15

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/4017164

2

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/4017164

149-152

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/4017164

PTG, a new antineoplastic epipodophyllotoxin

1 reference

https://pubmed.ncbi.nlm.nih.gov/4017164

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotoxin glucopyranoside derivatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/4017164

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The toxicity of massive dosis of VM26 (4-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside). A contribution to the therapy of advanced ovarian cancer (author's transl)

1 reference

https://pubmed.ncbi.nlm.nih.gov/4017164

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The podophyllotoxin derivatives VP16-213 and VM26.

1 reference

https://pubmed.ncbi.nlm.nih.gov/4017164

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical pharmacology of VM26 and VP16-213. A brief overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/4017164

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VM 26 and VP 16-213: a comparative analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/4017164

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Teniposide (VM26) disposition in children with leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/4017164

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of Ip cisplatin in refractory ovarian carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/4017164

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of Teniposide (VM26) and etoposide (VP16-213) in children with cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/4017164

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraperitoneal chemotherapy with melphalan

1 reference

https://pubmed.ncbi.nlm.nih.gov/4017164

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is it necessary to measure plasma levels of anticancer drugs?

1 reference

https://pubmed.ncbi.nlm.nih.gov/4017164

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy of the epipodophyllotoxin derivatives, teniposide and etoposide. A pharmacodynamic rationale?

1 reference

https://pubmed.ncbi.nlm.nih.gov/4017164

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of VM-26 in adult malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/4017164

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity and pharmacokinetics of teniposide in Lewis lung carcinoma-bearing mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/4017164

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00257526

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/4017164

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/4017164

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52680277&oldid=2211790441"